Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients.

Source:http://linkedlifedata.com/resource/pubmed/id/16268820

Download in:

View as

General Info

PMID
16268820